The DNA mutations that accumulate over time as women age are not the sole contributor to the higher frequency of breast cancer in women over 50, Mark LaBarge, PhD, a researcher at Lawrence Berkeley National Laboratory (LBNL) reported on Dec.
"Dan Sherman is a financial navigator. He helps cancer patients find financial support, "There are programs out there that will help with the large out of pocket responsibility that some patients have." A job he says has become a necessary part of planning cancer treatment, "Over the last 10 years there's been a huge shift of the financial burden being transferred to the patient versus the insurance provider." "
"We conducted a pragmatic, randomized controlled trial comparing acupuncture with enhanced usual care. Three hundred two outpatients with breast cancer participated. We randomly assigned 75 patients to usual care and 227 patients to acupuncture plus usual care (random assignment of 1:3 respectively) with minimization controlling for baseline general fatigue and maintenance treatment."
If it's unclear whether a patient's early-stage breast cancer has spread to lymph nodes in the armpit - typically the first place breast cancer spreads - the standard of care calls for a surgeon to perform a test known as the axillary sentinel...
"Until this study, the ribonucleic acid (RNA) molecule called miR-181a had never before been tied to breast cancer metastasis. But when scientists found elevated levels of the molecule in late-stage breast cancer tissues, they in turn tested an inhibitor in mouse models. The approach not only prevented metastasis, but also extended the animals' lives."